Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

Company Testing Vaccine Against Cervical Cancer




 

USA Today (06/18/98) P. 6D

Merck & Co. is currently conducting early stage clinical tests of a vaccine against cervical cancer in women to ensure that the drug is safe enough to be used in a larger study. While it is too early to determine if the vaccine will work, Merck's lead scientist, Kathrin Jansen, said the vaccine seemed highly effective in animal studies. Merck's goal is immunizing girls at about age10 before they become sexually active and increase their risk of contracting human papilloma virus (HPV), the most common sexually transmitted disease. Although HPV is often harmless to a majority of people, a small percentage of the women infected with the virus contract a dangerous strain that causes cervical cancer, which kills 5,000 Americans annually, according to the American Cancer Society.



 


Copyright © 1998 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in June 18, 1998. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.